信義玻璃(00868.HK)預計上半年純利約35.0億-26.9億港元 同比減少35%-50%
格隆匯6月24日丨信義玻璃(00868.HK)公佈,截至2022年6月30日止六個月,公司權益持有人應占的未經審核綜合純利金額預期較2021年上半年的純利53.8億港元,減少35%至50%,至35.0億港元與26.9億港元的範圍。
此減少乃基本於下列因素:(a)對比2021年上半年,由於中國建築市場的浮法玻璃需求受壓,使浮法玻璃產品平均售價於2022年上半年期內接連下降;及(b)與2022年上半年期內,因供應短缺,使能源及原材料成本大幅上升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.